Abstract：
Mast cells (MCs) can release a variety of biologically active mediators under different circumstances, such as fever or vaccination. Our aim was to evaluate the incidence and severity of MC activation symptoms induced by SARS-CoV-2 virus (COVID-19) infection and vaccination in a cohort of 92 pediatric patients with cutaneous mastocytosis. Our findings support previous evidence on the safety of COVID-19 infection and vaccination in patients with MC disorders.
摘要：
肥大细胞(MCs)在不同情况下可以释放多种生物活性介质,如发烧或接种疫苗。我们的目的是评估92例儿童皮肤肥大细胞增多症患者中SARS-CoV-2病毒（COVID-19）感染和疫苗接种引起的MC激活症状的发生率和严重程度。我们的发现支持了先前关于MC障碍患者COVID-19感染和疫苗接种安全性的证据。
